UroGen Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.

About URGN

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.

CEO

Elizabeth Barrett

CEOElizabeth Barrett

Employees

235

Employees235

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

2004

Founded2004

Employees

235

Employees235

URGN Key Statistics

Market cap

626.14M

Market cap626.14M

Price-Earnings ratio

-4.27

Price-Earnings ratio-4.27

Dividend yield

—

Dividend yield—

Average volume

2.02M

Average volume2.02M

High today

$13.62

High today$13.62

Low today

$12.89

Low today$12.89

Open price

$12.98

Open price$12.98

Volume

737.40K

Volume737.40K

52 Week high

$18.15

52 Week high$18.15

52 Week low

$3.42

52 Week low$3.42

URGN News

TipRanks 6h

UroGen Pharma Approves Bonuses After FDA Approval

Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights...

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

People also own

Based on the portfolios of people who own URGN. This list is generated using Robinhood data, and it’s not a recommendation.